Iridex (IRIX) FCF Margin Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 417.00 |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn | 889.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 889.00 |
| Jan 3, 2026 | 1,429.00 |
| Sep 27, 2025 | 540.00 |
| Jun 28, 2025 | 1,654.00 |
| Mar 29, 2025 | 1,474.00 |
| Dec 28, 2024 | -4,706.00 |
| Mar 30, 2024 | -11,235.00 |
| Sep 30, 2023 | -1,907.00 |
| Jul 1, 2023 | 2,311.00 |
| Apr 1, 2023 | -420.00 |
| Dec 31, 2022 | -938.00 |
| Oct 1, 2022 | 939.00 |
| Jul 2, 2022 | -605.00 |
| Apr 2, 2022 | 1,198.00 |
| Jan 1, 2022 | 5,555.00 |
| Apr 3, 2021 | 12,987.00 |
| Sep 26, 2020 | 2,289.00 |
| Jun 27, 2020 | -3,989.00 |
| Mar 28, 2020 | 186.00 |
| Dec 28, 2019 | 323.00 |
| Sep 28, 2019 | -314.00 |
| Jun 29, 2019 | -2,210.00 |
| Mar 30, 2019 | -4,013.00 |
| Dec 29, 2018 | 1,579.00 |
| Mar 31, 2018 | -3,360.00 |
| Sep 30, 2017 | -2,929.00 |
| Jul 1, 2017 | 266.00 |
| Apr 1, 2017 | -2,392.00 |
| Dec 31, 2016 | 207.00 |
| Oct 1, 2016 | -2,657.00 |
| Jul 2, 2016 | -245.00 |
| Apr 2, 2016 | 841.00 |
| Jan 2, 2016 | -3,760.00 |
| Apr 4, 2015 | 1,845.00 |
| Sep 27, 2014 | -173.00 |
| Jun 28, 2014 | 302.00 |
| Mar 29, 2014 | 1,451.00 |